Clinical Trial Update: Selective Treatment According to Molecular Subtype of Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update exploring selective treatment based on molecular subtype in prostate cancer, including castration-resistant and metastatic disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer Metastatic

Snippet

Sponsor: Tianjin Medical University Second Hospital | Conditions: Castration-resistant Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Status: UNKNOWN